Postmarketing Surveillance of New Food Ingredients: Results from the Program with the Fat Replacer Olestra
- 30 April 2001
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 33 (2) , 224-233
- https://doi.org/10.1006/rtph.2001.1460
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of Wheat Bran and Olestra on Objective Measures of Stool and Subjective Reports of Gi SymptomsAmerican Journal of Gastroenterology, 2000
- Positive Results on Tests for Steatorrhea in Persons Consuming Olestra Potato ChipsAnnals of Internal Medicine, 2000
- Vitamin K-Supplemented Snacks Containing Olestra: Implication for Patients Taking WarfarinPublished by American Medical Association (AMA) ,1999
- Effect of the Moderate Consumption of Olestra in P Receiving Long‐term Warfarin TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Olestra Postmarketing Surveillance Study: Design and Baseline Results from the Sentinel SiteJournal of the American Dietetic Association, 1998
- Gastrointestinal Symptoms Following Consumption of Olestra or Regular Triglyceride Potato ChipsJAMA, 1998
- Olestra: Assessing its potential to interact with drugs in the gastrointestinal tractClinical Pharmacology & Therapeutics, 1997
- Olestra, a Nonabsorbed, Noncaloric Replacement for Dietary Fat: A ReviewDrug Metabolism Reviews, 1997
- The effect of a non‐absorbable fat substitute, sucrose polyester, on gastrointestinal functionAlimentary Pharmacology & Therapeutics, 1996
- THE HALCION STORY: TRIAL BY MEDIAThe Lancet, 1980